Dec 12, 2011
WuXi PharmaTech (NYSE: WX), a leading pharmaceutical, biotechnology, and medical-device research and development outsourcing company with operations in China and the United States, today announced the winners of its fifth Life Science and Chemistry Awards, held on December 12, 2011 at Diaoyutai State Guesthouse in Beijing.
24/10/2011
WuXi PharmaTech Acquires China-Based Clinical Research Services Companies
13/10/2011 WuXi PharmaTech Acquires Abgent, a Leading Producer of Biological Research Reagents
06/16/2011
WuXi AppTec Named a Top Ten Chinese Outsourcing Enterprise
11/11/2010
WuXi PharmaTech Awarded GLP Certificate from SFDA for Suzhou Toxicology Facility
10/10/2010
WuXi PharmaTech Congratulates the 2010 Nobel Laureates in Chemistry
10/07/2010
Professor Steven V. Ley Speaks at WuXi PharmaTech
09/03/2010
Shanghai SynTheAll Pharmaceuticals Co., Ltd. (STA) Receives ISO 14001 Certification
WuXi Pharmatech Featured in The Fast Company 50 2009
Source: Fast Company, 2/11/2009
Right Mix
Source: ChinaDaily 3/24/2008
New prescription
Source: ChinaDaily 3/24/2008
No Slowdown for China's WuXi
Source: The Motley Fool 3/14/2008
Drug Makers Stick by China
Source: Boston Globe 3/14/2008
China's WuXi gets U.S. okay to buy AppTec
Source: Reuters 1/23/2008
Bringing it back to the States
Source: Contract Pharma 1/22/2008
WuXi's AppTec Deal Is Move For Bigger Market Share
Source: The Wall Street Journal 1/5/2008
Wuxi Makes $160 Million Offer for AppTec of U.S.
Source: Bloomberg 1/4/2008